Search Results

Displaying Results 3801-3825 of 20671 "'R'"

Jul 17, 2026, 01:55 ET Saab Q2 results 2026: Strong order bookings reinforce market position

https://news.cision.com/saab/r/saab-q2-results-2026--strong-order-bookings-reinforce-market-position,c4375551The following files are available for download:

More news about: Saab


Jul 17, 2026, 01:55 ET Sequential growth across all revenue streams

https://news.cision.com/truecaller-ab/r/sequential-growth-across-all-revenue-streams,c4375604The following files are available for download:

More news about: Truecaller AB


Jul 17, 2026, 01:51 ET EQT AB (publ) Half-year Report 2026

https://news.cision.com/eqt/r/eqt-ab--publ--half-year-report-2026,c4375599The following files are available for download:

More news about: EQT


Jul 17, 2026, 01:30 ET 神雲科技重磅登場世界人工智能大會,全方位基礎架構引領代理式 AI 新紀元

R2520G6 企業級伺服器專為儲存密度打造的2U雙路伺服器。R2520G6支援32個熱插拔NVMe E3.S。全線支援PCIe Gen5極速頻寬與1+1備援2,000W電源,消除高並發吞吐的I/O瓶頸,是企業建置地端資料庫的全能高效選擇。除三款明星單機外,展位同步展出了多款為邊緣運算及多元企業級

More news about: MiTAC Computing Technology Corporation


Jul 17, 2026, 01:30 ET Volvo Cars Q2 2026: executing in a very challenging environment

https://news.cision.com/volvo-car-ab--publ-/r/volvo-cars-q2-2026--executing-in-a-very-challenging-environment,c4375596The following files are available for download:

More news about: Volvo Car AB (publ)


Jul 17, 2026, 01:25 ET Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA

best-in-class potential are conceived based on the company's proprietary FluidCrystal® technology and its extensive R&D expertise. The R&D pipeline includes products for the treatment of dependence, pain, cancer, and endocrine diseases. Camurus has operations across Europe,

More news about: Camurus AB


Jul 17, 2026, 01:22 ET Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA

best-in-class potential are conceived based on the company's proprietary FluidCrystal® technology and its extensive R&D expertise. The R&D pipeline includes products for the treatment of dependence, pain, cancer, and endocrine diseases. Camurus has operations across Europe,

More news about: Camurus AB


Jul 17, 2026, 00:35 ET Truecaller enters into an agreement to acquire US-based TextPlus Inc.

https://news.cision.com/truecaller-ab/r/truecaller-enters-into-an-agreement-to-acquire-us-based-textplus-inc-,c4375602The following files are available for download:

More news about: Truecaller AB


Jul 17, 2026, 00:30 ET Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad

leadership, including Kate Benedict, SVP and President, Acute Care Monitoring; Jason Case, VP, R&D, Acute Care Monitoring; Dev Joshua, Sr. Director, Digital Health; and Gauri Joglekar, Sr. Director, Portfolio R&D and PMO – Innovation Delivery and Divya Prakash Joshi, VP, Engineering and Board Member,

More news about: Medtronic


Jul 16, 2026, 18:56 ET First Lawsuit in 2026 Multistate Cyclospora Outbreak Filed Against Taco Bell Operator in Ohio Federal Court

distributors of the fresh produce implicated in the outbreak, named as John Doe Corporations 1–5.According to the complaint, plaintiff Mohammed R. Ayyad ate meals at the North Olmsted Taco Bell on June 14 and again on June 21, 2026. He began experiencing symptoms of a Cyclospora infection

More news about: Marler Clark, The Food Safety Law Firm


Jul 16, 2026, 16:35 ET CON EDISON DECLARES COMMON STOCK DIVIDEND

gas service in Manhattan, the Bronx, parts of Queens and parts of Westchester, and steam service in Manhattan; Orange and Rockland Utilities, Inc. (O&R), a regulated utility serving customers in a 1,300-square-mile area in southeastern New York State and northern New Jersey; and Con Edison Transmission,

More news about: Consolidated Edison, Inc.


Jul 16, 2026, 16:30 ET Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pustular Psoriasis - A Milestone Recognition of GPP as a Distinct Rare Disease in Europe

10, 2026. [Online]. Available: https://www.nanbyou.or.jp/entry/168H. Fujita, R. Iwasaki, S. Tsuboi, Y. Murashiuma, and M. Akiyama, "Regional differences in the prevalence of generalized pustular psoriasis in Japan," J. Dermatol.,

More news about: Vanda Pharmaceuticals Inc.


Jul 16, 2026, 16:24 ET /C O R R E C T I O N -- Capacity/

More news about: Capacity


Jul 16, 2026, 15:43 ET Microsoft Corporation (MSFT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

its profitable Azure services in order to improve the competitive positioning of its critical Copilot family of products and increase its AI-related R&D; (4) that, as a result of the foregoing, Microsoft had failed to convert a significant percentage of its commercial Microsoft 365 users to paid Copilot

More news about: Glancy Prongay Wolke & Rotter LLP


Jul 16, 2026, 15:41 ET Calix, Inc. (CALX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz announces that investors with losses related to Calix, Inc. ("Calix" or the "Company") (NYSE:

More news about: The Law Offices of Frank R. Cruz, Los Angeles


Jul 16, 2026, 15:39 ET Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

under the applicable law and ethical rules.Contact Us: The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz, Telephone: 310-914-5007Email: [email protected]

More news about: The Law Offices of Frank R. Cruz, Los Angeles


Jul 16, 2026, 15:31 ET Embecta Corp. (EMBC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

under the applicable law and ethical rules.Contact Us: The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz, Telephone: 310-914-5007Email: [email protected]

More news about: The Law Offices of Frank R. Cruz, Los Angeles


Jul 16, 2026, 12:51 ET /C O R R E C T I O N -- Medik8/

More news about: Medik8


Jul 16, 2026, 12:12 ET /C O R R E C T I O N -- Overlord Labs/

More news about: Overlord Labs


Jul 16, 2026, 11:57 ET Blast Resources Announces Strong Uranium/Thorium Anomalies on Britts Lake Claims in Athabasca Basin Region, Saskatchewan

the Athabasca Basin, the Project is strategically located within the Patterson Lake Corridor which hosts two significant uranium deposits, the Triple R Deposit and the Arrow Deposit.  ON BEHALF OF THE BOARDCasey Forward

More news about: Blast Resources Inc


Jul 16, 2026, 11:30 ET Law Firm Business Development Program Generates More Than $9.3 Million in Revenue and 17,900% ROI in Under 12 Months

coaching, accountability, and a structured process.""One of the most significant findings was the change in attorney perceptions," said Keith R. Sbiral, Co-Founder and President of Apochromatik. "They came to realize business development isn't an innate talent that only certain attorneys possess.

More news about: Apochromatik


Jul 16, 2026, 11:21 ET /C O R R E C T I O N -- Mercuryo/

More news about: Mercuryo


Jul 16, 2026, 11:01 ET The Finnish Financial Supervisory Authority has approved WISA Group Plc's demerger and listing prospectus. WISA Group Plc's Group Leadership Team appointed

https://news.cision.com/upm-kymmene-oyj/r/the-finnish-financial-supervisory-authority-has-approved-wisa-group-plc-s-demerger-and-listing-prosp,c4375395 

More news about: UPM-Kymmene Oyj


Jul 16, 2026, 10:30 ET Oligonucleotide Synthesis Market worth $32.72 billion by 2031 - Exclusive Report by MarketsandMarkets™

and Inotersen for hereditary ATTR amyloidosis, have driven both analyst and investor confidence, fueling expanded manufacturing capacity and robust R&D pipelines.In 2025, the hospitals segment accounted for the largest share of the oligonucleotide-based drugs market.By end user,

More news about: MarketsandMarkets


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.